Dame Sally Davies on Antimicrobial Resistance
Listen now
Description
This week, CSIS co-hosted the 9th annual Atlanta Global Health Summit with the World Affairs Council of Atlanta, CARE USA, and The Carter Center. J. Stephen Morrison spoke with Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance and Master of Trinity College at Cambridge University. She is also the single most impactful person in the last decade on advancing the fight against antimicrobial resistance (AMR). She provides an update on the Trinity Challenge she co-founded that brings together experts from around the world to improve public health data. She shares her thoughts on why Covid-19 has put action against antimicrobial resistance into “suspended animation”, why AMR needs to be seen not as a “silent pandemic” but a central element of global health security, and some recent political advancements that give her hope. She also shares some of her personal journey as a science communicator and a pioneering woman leader, and what keeps her so optimistic when confronting massive global health challenges. Dame Sally Davies, the UK Special Envoy on Antimicrobial Resistance and Master of Trinity College at Cambridge University. Dame Sally previously served as the Chief Medical Officer for England, and the Chief Scientific Adviser at the Department of Health. You can catch up on all the conference sessions on the YouTube channel of the World Affairs Council of Atlanta.
More Episodes
Katherine is joined by Jeffrey L. Sturchio, Senior Associate (Non-Resident) with the CSIS Global Health Policy Center and co-author of the new report, The Ending the HIV Epidemic in the U.S. Initiative: An Interim Assessment and Policy Recommendations. The EHE initiative began in 2019 with a goal...
Published 12/16/22
Published 12/16/22
Dr. Heidi Larson, co-founder of the Global Listening Project and founding director of the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, joins Katherine to discuss the impacts of Covid-19 on global vaccine confidence and the importance of listening closely to...
Published 10/28/22